We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Two Immunotherapies Converted Into Single Therapy for Certain Blood Cancers

News   Jul 24, 2020 | Original story from Washington University School of Medicine in St. Louis

 
Two Immunotherapies Converted Into Single Therapy for Certain Blood Cancers

Researchers at Washington University School of Medicine in St. Louis have combined two types of immunotherapy into a single treatment that may be more effective and possibly safer than current immunotherapies for blood cancers. Shown is a type of immune cell called a memory-like natural killer cell (right) attacking a leukemia cell (left). In the new study, the researchers modified the natural killer cells to help them find the leukemia cells more effectively. Credit: Julia Wagner

 
 
Advertisement
 

RELATED ARTICLES

Genetically Engineered T Cells a Possible Therapy for Autoimmune Diseases

News

A genetically engineered T cell has been found to effectively target and attack pathogenic cells that cause type one diabetes.

READ MORE

Novel Role of Immune System in Psoriasis

News

Scientists have uncovered another one of the complex immune-mediated mechanisms behind the onset of psoriasis and severe psoriasis lesions. The work highlights potential therapeutic targets for future treatments.

READ MORE

Team Identifies Potential Drug Combo To Treat a Type of Eye Cancer

News

A promising new drug has been developed for the treatment of uveal melanoma in patients, which are aimed at targeting two specific genes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE